Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma

Clinical trial NCT05595447 · RECRUITING

Trial details

NCT number: NCT05595447
Sponsor: Hospital Regional de Alta Especialidad del Bajio
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hodgkin Lymphoma Refractory Hodgkin Lymphoma Relapsed Hodgkin's Disease, Adult

Start date: 2022-10-18
Primary completion: 2025-10-18
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.